MICHELE SEID: Open Payments
NPI 1023669348 · CENTRAL ISLIP, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 25 payments from 8 companies in 2025. Trend: 2023 $1,079 · 2024 $855 · 2025 $1,503
Food & beverage: $1,393Education: $109
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $429 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $423 |
| Teva Pharmaceuticals USA, Inc. | 6 | $244 |
| E.R. Squibb & Sons, L.L.C. | 4 | $204 |
| Alkermes, Inc. | 2 | $146 |
| Corium, LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: INGREZZA, CAPLYTA, COBENFY, LYBALVI, AUSTEDO XR, UZEDY, Azstarys, HETLIOZ.
Industry payments across NY — which companies pay providers there.
